LABS.TO · MediPharm Labs Corp.
Canada · RS rating 25 · As of 2026-10-14
| Price | 0.06 CAD |
|---|---|
| 1-day change | -7.1% |
| RS rating (overall / 1M / 3M / 12M) | 25 / 24 / 22 / 26 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 14 / 19 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +11.4% |
| Distance from 52-week high | +27.8% |
| Market cap (USD) | $21.0M |